Sirolimus Pregnancy and Breastfeeding Warnings
Sirolimus is also known as: Rapamune
Sirolimus Pregnancy Warnings
Sirolimus has been assigned to pregnancy category C by the FDA. Animal studies have revealed evidence of embryotoxicity and fetotoxicity. There are no controlled data in human pregnancy. The manufacturer recommends use effective contraception in women of childbearing age before, during, and for 12 weeks after the completion of sirolimus therapy. Sirolimus should only be given during pregnancy when there are no alternatives and benefit outweighs risk.
Azoospermia has been reported with the use of sirolimus and has been reversible upon discontinuation of sirolimus in most cases.
Sirolimus Breastfeeding Warnings
Sirolimus is excreted in the milk of lactating rats.
There are no data on the excretion of sirolimus into human milk. Because many drugs are excreted into human milk and because of the potential for adverse reactions to sirolimus in nursing infants, the manufacturer recommends that a decision be made whether to discontinue nursing or to discontinue sirolimus, taking into account the importance of the drug to the mother.
See Also...
- Sirolimus use while Breastfeeding (in more detail)
- sirolimus Consumer Information
- Pregnancy Support Group
- FDA Pregnancy Categories
- Medicine use during Pregnancy
- Medicine use while Breastfeeding
- Safe Medications during Breastfeeding
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This drug information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.
